Innoviva (INVA) Operating Expenses (2010 - 2026)

Innoviva (INVA) has 17 years of Operating Expenses data on file, last reported at $37.7 million in Q1 2026.

• Quarterly Operating Expenses rose 18.16% year-over-year to $37.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $179.3 million (up 14.55% YoY) and the FY2025 annual result came in at $143.9 million, up 11.27% from the prior year.
• Operating Expenses retreated to $37.7 million in Q1 2026, from $107.2 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $107.2 million in Q3 2025 to a low of -$219.2 million in Q3 2022.
• A 5-year average of $37.4 million and a median of $37.7 million in 2026 frame the typical range for Operating Expenses.
• The widest YoY moves for Operating Expenses: up 1956.38% in 2022, down 109.53% in 2022.
• Tracing INVA's Operating Expenses over 5 years: stood at -$219.2 million in 2022, then jumped by 141.85% to $91.7 million in 2023, then climbed by 2.86% to $94.4 million in 2024, then grew by 13.66% to $107.2 million in 2025, then slumped by 64.87% to $37.7 million in 2026.
• The last three Operating Expenses figures came in at $37.7 million (Q1 2026), $107.2 million (Q3 2025), and $34.4 million (Q2 2025), per Business Quant data.